Consensus Zimmer Biomet Holdings, Inc.

Equities

ZBH

US98956P1021

Real-time Estimate Cboe BZX Other stock markets 12:43:32 2024-05-08 pm EDT			5-day change	1st Jan Change
120.2 ^USD	-1.02%		+0.72%	-1.05%

May. 03	Raymond James Adjusts Price Target on Zimmer Biomet Holdings to $138 From $142	MT
May. 03	UBS Adjusts Price Target on Zimmer Biomet Holdings to $112 From $109, Maintains Sell Rating	MT

Evolution of the average Target Price on Zimmer Biomet Holdings, Inc.

Price target over the last 5 years

History of analyst recommendation changes

2c3c3af480c42b4c0cf2.0zUsgJN0C0BdSA4QwZiQMJzFvzkDiFVOMcvd2FKejDg.vGwdtP0bQDltA2ldjdTUadj8iFxvwDx3a5-PuiOzyA29cl7R4Bh_CWQEPg~d4a255f4d2a49ad5112f3019ef7fd851

Analyst Recommendations on Zimmer Biomet Holdings, Inc.

Raymond James Adjusts Price Target on Zimmer Biomet Holdings to $138 From $142	May. 03	MT
UBS Adjusts Price Target on Zimmer Biomet Holdings to $112 From $109, Maintains Sell Rating	May. 03	MT
Truist Adjusts Zimmer Biomet Holdings' PT to $130 From $137, Keeps Hold Rating	May. 03	MT
Bernstein Adjusts Price Target on Zimmer Biomet to $133 From $132	May. 03	MT
Jefferies Adjusts Price Target on Zimmer Biomet to $135 From $136	May. 03	MT
Citigroup Adjusts Price Target on Zimmer Biomet to $134 From $140	May. 03	MT
Morgan Stanley Adjusts Price Target on Zimmer Biomet to $130 From $135	May. 03	MT
Jefferies Adjusts Zimmer Biomet Price Target to $135 From $136	May. 03	MT
Citigroup Adjusts Zimmer Biomet Price Target to $134 From $140	May. 03	MT
Morgan Stanley Adjusts Zimmer Biomet Price Target to $130 From $135	May. 03	MT
Oppenheimer Adjusts Price Target on Zimmer Biomet Holdings to $155 From $150	May. 03	MT
BTIG Adjusts Price Target on Zimmer Biomet to $139 From $138, Keeps Buy Rating	May. 02	MT
Truist Securities Adjusts Zimmer Biomet Price Target to $137 From $135, Hold Rating Kept	Apr. 15	MT
Citigroup Raises Price Target on Zimmer Biomet to $140 From $134, Keeps Neutral Rating	Apr. 03	MT
UBS Adjusts Zimmer Biomet Price Target to $109 From $105, Maintains Sell Rating	Feb. 09	MT
Deutsche Bank Adjusts Zimmer Biomet Price Target to $140 From $147, Maintains Hold Rating	Feb. 09	MT
UBS Raises Zimmer Biomet Price Target to $105 From $99, Maintains Sell Rating	Jan. 22	MT
RBC Raises Price Target on Zimmer Biomet Holdings to $140 From $134, Keeps Outperform Rating	Jan. 12	MT
Evercore ISI Downgrades Zimmer Biomet to In Line From Outperform, Adjusts Price Target to $125 From $135	Jan. 04	MT
Raymond James Raises Zimmer Biomet's Price Target to $137 From $133, Maintains Outperform Rating	Jan. 03	MT
Truist Adjusts Price Target on Zimmer Biomet Holdings to $133 From $115, Maintains Hold Rating	Dec. 22	MT
Euphoria subsides for Triple-Witching Day	Dec. 15
ANALYST RECOMMENDATIONS : Adobe, Blackrock, Roblox, Snap, US Bancorp...	Dec. 15
Morgan Stanley Raises Zimmer Biomet Price Target to $125 From $120, Maintains Equal Weight Rating	Dec. 04	MT
JMP Securities Adjusts Price Target on Zimmer Biomet Holdings to $140 From $160, Maintains Market Outperform Rating	Nov. 13	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

121.4 USD

Average target price

136.6 USD

Spread / Average Target

+12.50%

High Price Target

175 USD

Spread / Highest target

+44.12%

Low Price Target

112 USD

Spread / Lowest Target

-7.77%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Zimmer Biomet Holdings, Inc.

Raymond James
UBS
Truist Securities
Bernstein
Jefferies & Co.
Citigroup
Morgan Stanley
Oppenheimer
BTIG
Deutsche Bank Securities
RBC Capital Markets
Evercore ISI
JMP Securities
Barclays
Stifel Nicolaus
JPMorgan Chase
Baird
BofA Securities
Piper Sandler
Wells Fargo Securities
Goldman Sachs
Needham & Co.
SVB Leerink
Guggenheim
Loop Capital
Canaccord Genuity
Argus
Ned Davis Research
J.P. Morgan Chase
Northland Securities

Ratings for Zimmer Biomet Holdings, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar